Vision in Parkinson's disease: What are the deficits and what are their origins?

Neuro-Ophthalmology

Volumn 19, Issue 3, 1998, Pages 113-135

  Harris, John ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Colour; Parkinson's disease; Spatial; Temporal; Vision

Indexed keywords

DOPAMINE;

COLOR VISION; ELECTROPHYSIOLOGY; EYE MOVEMENT; MOTION; PARKINSON DISEASE; PATHOGENESIS; REVIEW; SPATIAL DISCRIMINATION; TIME PERCEPTION; VISUAL ACUITY; VISUAL CORTEX; VISUAL IMPAIRMENT;

EID: 0031835860     PISSN: 01658107     EISSN: None     Source Type: Journal    
DOI: 10.1076/noph.19.3.113.7896     Document Type: Review

References (130)

1. Parkinson, J. An Essay on the Shaking Palsy. London: Sherwood, Neely, and Jones, 1817.
2. Sullivan EV, Sagar HJ. Double dissociation of short-term and long-term memory for non-verbal material in Parkinson's disease and global amnesia. Brain 1991;114:893-906.
3. Illes J. Neurolinguistic features of spontaneous language production dissociate three forms of neurodegenerative disease: Alzheimer's, Huntington's and Parkinson's. Brain Lang 1989;37:628-642.
4. Sharpe MH. Distractibility in early Parkinson's disease. Cortex 1990;26:239-246.
5. Hornykiewicz O. Dopamine (3-hydroxytryptamine) and brain function. Pharmacol Rev 1966;18:925-963.
6. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the symptoms of Parkinson and Huntingdon: clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-455.
7. Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y. Reduction of cortical dopamine, noradrenalin, serotonin and their metabolites in Parkinson's disease. Brain Res 1983;275:321-328.
8. Frederick JM, Rayborn ME, Laties AM, Lam DMK, Hollyfield JG. Dopaminergic neurons in the human retina. J Comp Neurol 1982;210:65-69.
9. Bodis-Wollner I, Piccolino M. Dopaminergic Mechanisms in Vision. New York: AR Liss, Inc., 1988.
10. Herrera AJ, Machado A, Cano J. Aging and monoamine turnover in the lateral geniculate nucleus and visual cortex of the rat. Neurochem Int 1993;22:531-539.
11. Berger B, Caspar P, Verney C. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci 1991;14:21-27.
12. Chevalier G, Deniau JM. Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci 1990;13:277-280.
13. Critchley M. The Parietal Lobes. London: Arnold, 1953.
14. McCarthy R, Warrington EK. Cognitive Neuropsychology: a Clinical Introduction. London: Academic Press, 1990.
15. Rutcliff G, Davies-Jones GAB. Defective visual localization in focal brain wounds. Brain 1972;95:46-60.
16. Patterson A, Zangwill OL. Disorders of visual space perception associated with lesions of the right cerebral hemisphere. Brain 1944;67:331-358.
17. Benton AL, Hannay J, Varney AR. Visual perception of line direction in patients with unilateral brain disease. Neurology 1975;25:907-910.
18. Layman S, Greene E. The effect of stroke on object recognition. Brain Cognition 1988;7:87-114.
19. De Renzi E. Disorders of Space Exploration and Cognition. New York: Wiley, 1982.
20. McFie J, Zangwill OL. Visual-constructive disabilities associated with lesions of the left cerebral hemisphere. Brain 1960;83:243-260.
21. Rafal R, Robertson L. The neurology of visual attention. In: Gazzinaga M, editor. The Cognitive Neurosciences. Cambridge, MA: MIT Press, 1995; 625-648.
22. Corbetta M, Shulman GL, Miezin FM, Petersen SE. Superior parietal cortex activation during spatial attention shifts and visual feature conjunction search. Science 1995;270:802-805.
23. Heide W, Kurzidim K, Koempf D. Deficits of smooth pursuit eye movements after frontal and parietal lesions. Brain 1996;119:1951-1969.
24. Teuber HL, Mishkin M. Judgement of visual and postural vertical after brain injury. J Psychol 1954;38:161-175.
25. Heilman KM, Valenstein E Frontal lobe neglect in man. Neurology 1972;22:660-664.
26. Nobre AC, Sebestyen GN, Gitelman DR, Mesulam MM, Frackowiak RSJ, Frith CD. Functional localization of the system for visuospatial attention using positron emission tomography. Brain 1997;128:515-533.
27. Dean P, Redgrave P, Westby GWM. Event or emergency? Two response systems in the mammalian superior colliculus. Trends Neurosci 1989;12:137-147.
28. Brown RG, Marsden CD. Visuospatial function in Parkinson's disease. Brain 1986;109:987-1002.
29. Lee AC, Harris JP, Calvert JE. Impairments of mental rotation in Parkinson's disease. Neuropsychologia, 1998;36:209-214.
30. Danta G, Hilton RC. Judgement of visual vertical and horizontal in patients with parkinsonism. Neurology 1975;25:43-47.
31. Orban G, Vandenbussche E, Vogels R. Human orientation discrimination tested with long stimuli. Vision Res 1984;24:121-128.
32. Fahle M, Harris JP. The use of different orientation cues in vernier acuity. Percept Psychophys, in press.
33. Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M Visual dysfunction in Parkinson's disease: loss in spatiotemporal contrast sensitivity. Brain 1987;110:1675-1698.
34. Harris JP, Calvert JE, Phillipson OT. Processing of spatial contrast in peripheral vision in Parkinson's disease. Brain 1992;115:1447-1457.
35. Harris JP, Calvert JE, Leendertz JA, Phillipson OT. The influence of dopamine on spatial vision. Eye 1990;4:806-812.
36. Hutton JT, Morris JL, Elias JW, Varma R, Poston JN. Spatial contrast sensitivity is reduced in bilateral Parkinson's disease. Neurology 1991;41:1200-1202.
37. Hoehn MH, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427:442.
38. Bulens C, Meerwaldt JD, Van der Wildt G, Keemink CJ. Contrast sensitivity in Parkinson's disease. Neurology 1986;36:1121-1125.
39. Bulens C, Meerwaldt JD, Van der Wildt GJ. Effect of stimulus orientation on contrast sensitivity in Parkinson's disease. Neurology 1988;38:76-81.
40. Regan D, Maxner C. Orientation-dependent loss of contrast sensitivity for pattern and flicker in multiple sclerosis. Clin Vision Sci 1986;1:1-23.
41. Apkarian P, Tijssen R, Spekriejse H, Regan D Origin of notches in CSF: optical or neural? Invest Ophthalmol Visual Sci 1987;28:607-612.
42. Woods RL, Bradley A, Atchison DA. Consequences of monocular diplopia for the contrast sensitivity function. Vision Res 1996;36:3587-3596.
43. Strang NC, Atchison DA, Woods RL. Predicting variations in visual performance caused by optical defects - 2. In: Vision Science and its Applications, Vol. 1. 1997 OSA Technical Digest Series. Washington DC: Optical Society of America, 1996; 60-63.
44. Regan D, Maxner C. Orientation-selective visual loss in patients with Parkinson's disease. Brain 1987;110:415-432.
45. Hubel DH, Wiesel TN. Receptive fields, binocular interaction and functional architecture in the cat's visual cortex. J Physiol 1962;160:106-154.
46. Hubel DH, Wiesel TN. Receptive fields and functional architecture of monkey striate cortex. J Physiol 1968;195:215-243.
47. Regan D. Visual sensory loss in patients with Parkinson's disease. In: Bodis-Wollner I, Piccolino M, editors. Dopaminergic Mechanisms in Vision. New York: AR Liss, Inc., 1988; 221-225.
48. Kennedy H, Martin KAC, Orban GA, Whitteridge D. Receptive field properties of neurones in visual area 1 and visual area 2 in the baboon. Neuroscience 1985;14:405-415.
49. Trick GL, Kaskie B, Steinman SB. Visual impairment in Parkinson's disease: deficits in orientation and motion discrimination. Optometry Visual Sci 1994;71:242-245.
50. Calvert JE, Harris JP, Phillipson OT. Effects of L-dopa on the tilt aftereffect with differing stimulus contrast and test duration. Clin Vision Sci 1990;5:87-93.
51. Calvert JE, Harris JP, Phillipson OT. Probing the visual system of Parkinson's disease and chronic schizophrenic patients on depot neuroleptic using the tilt aftereffect. Clin Vision Sci 1992;7:119-127;
52. Harris JP, Calvert JE. Contrast, spatial frequency and test duration effets on the tilt aftereffect: implications for underlying mechanisms. Vision Res 1989;29:129-135.
53. Ohzawa I, Sclar G, Freeman RD. Contrast gain control in the cat's visual system. J Neurophysiol 1985;54:651-667.
54. Mariani AP, Kolb H, Nelson R. Dopamine-containing amacrine cells of rhesus monkey retina parallel rods in spatial distribution. Brain Res 1984;322:1-7.
55. Ikeda H, Priest TD, Robbins J, Wakakuwa K. Silent dopaminergic synapse at feline retinal ganglion cells. Clin Vision Sci 1986;1:25-38.
56. Haug BA, Kolle RU, Trenkwalder C, Arden GB, Oertel WH, Paulus W. Predominant affection of the blue cone pathway in Parkinson's disease. Brain 1995;118:771-778.
57. Jones RD, Donaldson IM, Timmings PL. Impairment of high contrast visual acuity in Parkinson's disease. Movement Disord 1992;7:232-238.
58. Jones RD, Donaldson IM. Fractionation of visuoperceptual dysfunction in Parkinson's disease. J Neurol Sci 1995;131:43-50.
59. Bodis-Wollner I. Altered spatio-temporal contrast vision in Parkinson's disease and MPTP-treated monkeys: the role of dopamine. In: Bodis-Wollner I, Piccolino M, editors. Dopaminergic Mechanisms in Vision. New York: AR Liss, Inc., 1988; 205-220.
60. Mestre D, Blin O, Serratrice G, Pailhous J. Spatiotemporal contrast sensitivity differs in normal aging and Parkinson's disease. Neurology 1990;40:1710-1714.
61. Haug BA, Trenkwalder C, Arden GB, Oertel WH, Paulus W. Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease. Movement Disord 1994;9:563-570.
62. Blin O, Mestre D, Masson G, Serratrice G. Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled study. Br J Clin Pharmacol 1991;32:551-556.
63. Livingstone MS, Hubel DH. Psychophysical evidence for separate channels in the perception of form, colour, movement, and depth. J Neurosci 1987;7:3416-3468.
64. Price MJ, Feldman RG, Adelberg D, Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 1992;42:887-890.
65. Buettner Th, Kuhn W, Klotz P, Steinberg R, Voss L, Bulgaru D, Pruntzek H. Disturbance of colour perception in Parkinson's disease. J Neural Transm (PD section) 1993;6:11-15.
66. Buettner Th, Kuhn W, Mueller Th, Patzold T, Heidbrink K, Przuntek H. Distorted color discrimination in 'de novo' parkinsonian patients. Neurology 1995;45:386-387.
67. Buettner Th, Kuhn W, Przuntek H. Alterations in chromatic contour perception in Parkinson's disease. Eur Neurol 1995;35:226-229.
68. Meadows JC. Disturbed perception of colours associated with localized cerebral lesions. Brain 1974;97:615-632.
69. Wooten BR. Partial cerebral achromatopsia with selective hue loss. Doc Ophthalmol Proc Soc 1982;33:139-144.
70. Cronin-Colomb A, Corkin S, Rizzo JF, Cohen J, Growdown JH, Banks KS Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol 1991;29:41-52.
71. Buettner Th, Kuhn W, Patzold T, Przuntel H. L-dopa improves colour vision in Parkinson's Disease. J Neural Transm (PD section) 1994;7:13-19.
72. Buettner Th, Kuhn W, Mueller Th, McMonagle U, Przuntek H. Pharmacological effects of dopaminergics and amantadine on color discrimination in Parkinson's disease. Neuroophthalmology 1995;15:135-141.
73. Sandberg MA, Berson EL. Blue and green cone mechanisms in retinitis pigmentosa. Invest Ophthalmol Visual Sci 1997;16:149-157.
74. Hood DC, Benimoff NI, Greenstein VC. The response range of the blue-cone pathways: a source of vulnerability to disease. Invest Opthalmol Visual Sci 1984;25:864-867.
75. Ehinger B. Functional role of dopamine in the retina. In: Osborne NN, Chader GJ, editors. Progress in Retinal Research, Vol. 2. Oxford: Pergamon Press, 1983; 213-232.
76. Cogan DC. Brain lesions and eye movements in man. In: Bender M, editor. The Oculomotor System. New York: Harper and Row, 1964; 417-423.
77. Cogan DC. Paralysis of down-gaze. Arch Ophthalmol 1974;91:192-199.
78. De Jong JD, Melvill Jones G. Akinesis, hypokinesia and bradykinesia in the oculomotor system of patients with Parkinson's disease. Exp Neurol 1971;32:58-68.
79. Bronstein AM, Kennard C. Predictive ocular motor control in Parkinson's disease. Brain 1985;108:925-940.
80. Flowers KA. Some frequency response characteristics of Parkinson's disease. Brain 1978;101:19-34.
81. Crawford TJ, Henderson L, Kennard C. Abnormalities of nonvisually-guided eye movements in Parkinson's disease. Brain 1989;112:1573-1586.
82. Flowers KA. Lack of prediction in the motor behaviour of Parkinson's disease. Brain 1978;101:35-52.
83. Kowler E. The role of visual and cognitive processes in the control of eye movement. In: Kowler E, editor. Eye Movements and Their Role in Visual and Cognitive Processes. Amsterdam: Elsevier Science Publishers, 1990;1-70.
84. Robson JG. Spatial and temporal contrast-sensitivity functions of the visual system. J Opt Soc Am 1966;56:1141-1142.
85. Ratliff F, Riggs LA. Involuntary movements of the eyes during monocular fixation. J Exp Psychol 1950;40:687-701.
86. Ditchburn RW. Eye movements in relation to retinal action. Opt Acta 1955;1:171-176.
87. Bodis-Wollner I, Yahr M. Measurement of visual evoked potentials in Parkinson's disease. Brain 1978;101:661-671.
88. Dinner DS, Lueders H, Hanson M, Lisser RP, Klein G. Pattern evoked potentials (PEPs) in Parkinson's disease. Neurology 1985;35:610-613.
89. Ehle AL, Stewart RM, Lellelid NE, Leventhal NA. Normal checkerboard pattern reversal evoked potentials in parkinsonism. Electroencephalogr Clin Neurophysiol 1982;35:610-613.
90. Hansch EC, Syndulko K, Cohen SN, Goldberg ZI, Potvin AR, Tourtellotte WW. Cognition in PD: an event-related potential perspective. Ann Neurol 1982;11:599-607.
91. Nightingale S, Mitchell KW, Howe JW. Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects. J Neurol Neurosurg Psychiatry 1986;49:1280-1287.
92. Gawel MJ, Das P, Vincent S, Rose FC. Visual and auditory evoked responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1981;44:227-232.
93. Tartaglione A, Pizio N, Bino G, Spadavecchia L, Favale E. VEP changes in Parkinson's disease are stimulus dependent. J Neurol Neurosurg Psychiatry 1984;47:305-307.
94. Onofrj M, Ghilardi MF, Bascioni M, Gambi D. Visual evoked potentials in Parkinson's disease and dopamine blockade reveal stimulus-dependent dopamine function in humans. J Neurol Neurosurg Psychiatry 1986;49:1150-1159.
95. Verna NP. Pattern evoked potential changes in Parkinson's disease are stimulus dependent. Neurology 1985;35:1675-1676.
96. Bodis-Wollner I. The visual system in Parkinson's disease. In: Cohen B, Bodis-Wollner I, editors. Vision and the Brain. New York: Raven Press, 1990; 297-316.
97. Marx M, Bodis-Wollner I, Bobak B, Hornais C, Mylin L, Yahr MD. Temporal frequency-dependent VEP changes in Parkinson's disease. Vision Res 1986;26:185-193.
98. Gottlob I, Schneider E, Heider W, Skandries W. Alteration of visual evoked potentials and electroretinograms in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1987;66:349-357.
99. Daniels R, Harding GFA, Anderson SJ. Effect of dopamine and acetylcholine on the visual evoked potential. Int J Psychophysiol 1994;16:251-261.
100. Ellis CJK, Ikeda H. Evidence for retinal dopamine deficiency in Parkinson's disease. In: Bodis-Wollner I, Piccolino M, editors. Dopaminergic Mechanisms in Vision. New York: AR Liss, Inc., 1988; 239-251.
101. Stanzione P, Pierelli F, Peppe A , Stefano E, Rizzo PA , Morocutti C, Bernardi G. Pattern visual evoked potentials and electroretinogram abnormalities in Parkinson's disease: effects of L-dopa therapy. Clin Vision Sci 1989;4:115-127.
102. Tomita T, Yanagita T. Origins of the ERG waves. Vision Res 1981;21:1703-1707.
103. Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol 1996;100:1-11.
104. Iudice A, Vergili P, Muratorio A. The electroretinogram in Parkinson's disease. Psychol Psychiatr Behav 1980;5:283-289.
105. Kupersmith MJ, Shakin E, Siegel IM, Lieberman A. Visual system abnormalities in patients with Parkinson's disease. Arch Neurol 1982;39:284-286.
106. Murayama K, Adachi-Usami E, Yamada T. Effects of L-dopa on electroretinographic responses and pattern visual evoked potentials in juvenile parkinsonism. Clin Vision Sci 1989;3:265-268.
107. Krejkova H, Jarabak J, Filipova M, Bojar M, Poleehova P. Vestibulooeular and ERG changes in Parkinson patients. J Neurol 1985:232 (Suppl.): 130.
108. Ellis CJK, Allen TGJ, Marsden CD, Ikeda H. Retinal dopamine function in idiopathic Parkinson's disease. Clin Vision Sci 1987;1:347-355.
109. Jaffe MJ, Bruno G, Campbell G, Lavine RA, Karson CN, Weinberger DR. Ganzfeld electroretinographic findings in parkinsonism: untreated patients and the effects of levodopa intravenous infusion. J Neurol Neurosurg Psychiatry 1987;50:847-852.
110. Gottlob I, Weghaupt H, Vass C, Auff E. Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials. Graefe's Arch Clin Exp Ophthalmol 1989;227:421-427.
111. Cavallaci G, Perossini M, Wirth A. The interest of electroretinography in Parkinsonism. Doc Ophthalmol (Proc Ser) 1979;23:121-125.
112. Peppe A, Stanzione P, Pierelli F, Stefano E, Rizzo PA, Tagliati M, Morocutti C. Low contrast stimuli enhance PERG sensitivity to the visual dysfunction in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1992;82:453-457.
113. Barbato L, Rinalduzzi S, Laurenti M, Ruggieri S, Accornero N. Color VEPs in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1994;92:169-172.
114. Bucttner Th, Kuhn W, Mueller Th, Heinze T, Puhl C, Przuntek H. Chromatic and achromatic visual evoked potentials in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1996;100:443-447.
115. Fahn S, Elton RC and UPDRS Development Committee. United Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent Developments in Parkinson's Disease. New York: Macmillan Health Care Information, 1987; 153-164.
116. Mitchell DE. The influence of early visual experience on visual perception. In: Harris CS, editor. Visual Coding and Adaptability. New Jersey: Erlbaum, 1980; 1-50.
117. Beaumont SM, Harris JP, Leendertz JA, Phillipson OT. The pupillary light reflex in mild Parkinson's disease. Clin Vision Sci 1987;2:123-129.
118. Pirie A. Color and solubility of the proteins of human cataracts. Invest Ophthalmol 1968;7:634-650.
119. Nguyen-Legros J, Savy C. Dopamine innervation of the vertebrate retina: morphological studies. In: Bodis-Wollner I, Piccolino M, editors. Dopaminergic Mechanisms in Vision. New York: AR Liss, Inc., 1988; 1-17.
120. 14C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease. Neurology 1975;25:1-8.
121. Struck LK, Rodnitzky RL, Dobson JK. Circadian fluctuations of contrast sensitivity in Parkinson's disease. Neurology 1990;40:467-470.
122. Skandries W, Gottlob I. Alterations of visual contrast sensitivity in Parkinson's disease. Hum Neurobiol 1986;5:255-259.
123. Bodis-Wollner I, Onofroj M. The visual system in Parkinson's disease. Adv Neurol 1986;45:323-327.
124. Masson G, Mestre D, Blin O. Dopaminergic modulation of visual sensitivity in man. Fundam Clin Pharmacol 1993;7:449-463.
125. Iuvone PM. Dopamine: a light-adaptive modulator of melatonin synthesis in the frog retina. In: Bodis-Wollner I, Piccolino M, editors. Dopaminergic Mechanisms in Vision. New York: AR Liss. Inc., 1988; 95-107.
126. Vicars WM, Lit A. Reaction time to incremental and decremental target luminance changes at various photopic background levels. Vision Res 1975;16:1283-1287.
127. Rogers BJ, Anstis SM. Intensity vs adaptation and the Pulfrich stereophenomenon. Vision Res 1972;12:909-928.
128. Tepas DI, Armington JC. Properties of evoked visual potentials. Vision Res 1962;2:449-461.
129. Troelstra A, Schweitzer NMJ. An analysis of the b-wave in the human ERG. Vision Res 1963;3:213-226.
130. Calvert JE, Harris JP. Spatial frequency and duration effects on the tilt illusion and orientation acuity. Vision Res 1988;28:1051-1059.